Published in Nucleic Acids Res on April 15, 2003
Developing three-dimensional models of putative-folding intermediates of the HDV ribozyme. Structure (2010) 1.49
Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme. Curr Med Chem (2003) 1.10
Cross-linking experiments reveal the presence of novel structural features between a hepatitis delta virus ribozyme and its substrate. RNA (2004) 0.98
Modulating RNA structure and catalysis: lessons from small cleaving ribozymes. Cell Mol Life Sci (2009) 0.96
Functional characterization of the SOFA delta ribozyme. RNA (2005) 0.95
Gene targeting in the Gram-Positive bacterium Lactococcus lactis, using various delta ribozymes. Appl Environ Microbiol (2006) 0.89
A novel structural rearrangement of hepatitis delta virus antigenomic ribozyme. Nucleic Acids Res (2007) 0.88
Examination of the folding pathway of the antigenomic hepatitis delta virus ribozyme reveals key interactions of the L3 loop. RNA (2006) 0.84
Antigenomic delta ribozyme variants with mutations in the catalytic core obtained by the in vitro selection method. Nucleic Acids Res (2006) 0.84
Characterization of the trans Watson-Crick GU base pair located in the catalytic core of the antigenomic HDV ribozyme. PLoS One (2012) 0.83
A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease. PLoS One (2011) 0.78
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Kinetic intermediates in RNA folding. Science (1994) 3.07
The hammerhead, hairpin and VS ribozymes are catalytically proficient in monovalent cations alone. Chem Biol (1998) 3.01
Crystallization and structure determination of a hepatitis delta virus ribozyme: use of the RNA-binding protein U1A as a crystallization module. J Mol Biol (2000) 2.09
Evidence that genomic and antigenomic RNA self-cleaving elements from hepatitis delta virus have similar secondary structures. Nucleic Acids Res (1991) 1.63
Ribozyme structures and mechanisms. Annu Rev Biochem (2000) 1.47
Catalytic strategies of the hepatitis delta virus ribozymes. Annu Rev Biochem (2001) 1.45
A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes. RNA (1999) 1.39
Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo. RNA (2002) 1.13
Nucleotides -1 to -4 of hepatitis delta ribozyme substrate increase the specificity of ribozyme cleavage. Antisense Nucleic Acid Drug Dev (2000) 1.10
Kinetic analysis of delta ribozyme cleavage. Biochemistry (1998) 1.10
Substrate specificity of delta ribozyme cleavage. J Biol Chem (1998) 1.09
Hepatitis delta virus ribozymes fold to generate a solvent-inaccessible core with essential nucleotides near the cleavage site phosphate. Biochemistry (1996) 1.05
Requirement for canonical base pairing in the short pseudoknot structure of genomic hepatitis delta virus ribozyme. Nucleic Acids Res (2000) 1.02
Imino proton NMR analysis of HDV ribozymes: nested double pseudoknot structure and Mg2+ ion-binding site close to the catalytic core in solution. Nucleic Acids Res (2002) 1.01
The kinetics and magnesium requirements for the folding of antigenomic delta ribozymes. Biochem Biophys Res Commun (2000) 1.01
Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus. Nucleic Acids Res (2002) 0.98
Kinetic and binding analysis of the catalytic involvement of ribose moieties of a trans-acting delta ribozyme. J Biol Chem (2002) 0.98
Presence of a coordinated metal ion in a trans-acting antigenomic delta ribozyme. Nucleic Acids Res (1999) 0.96
Delta ribozyme has the ability to cleave in transan mRNA. Nucleic Acids Res (1999) 0.95
Energetic contribution of non-essential 5' sequence to catalysis in a hepatitis delta virus ribozyme. EMBO J (2001) 0.88
Developing three-dimensional models of putative-folding intermediates of the HDV ribozyme. Structure (2010) 1.49
5'-UTR G-quadruplex structures acting as translational repressors. Nucleic Acids Res (2010) 1.49
Exceptional structured noncoding RNAs revealed by bacterial metagenome analysis. Nature (2009) 1.43
The complete VS ribozyme in solution studied by small-angle X-ray scattering. Structure (2008) 1.34
A structural database for k-turn motifs in RNA. RNA (2010) 1.26
Nucleobase catalysis in the hairpin ribozyme. RNA (2006) 1.26
Ro-associated Y RNAs in metazoans: evolution and diversification. Mol Biol Evol (2007) 1.24
The ubiquitous hammerhead ribozyme. RNA (2012) 1.24
Alternative splicing of SYK regulates mitosis and cell survival. Nat Struct Mol Biol (2011) 1.17
High-throughput quantification of splicing isoforms. RNA (2009) 1.16
SubViral RNA: a database of the smallest known auto-replicable RNA species. Nucleic Acids Res (2003) 1.16
Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo. RNA (2002) 1.13
Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme. Curr Med Chem (2003) 1.10
Exploring mRNA 3'-UTR G-quadruplexes: evidence of roles in both alternative polyadenylation and mRNA shortening. Nucleic Acids Res (2013) 1.07
Target-dependent on/off switch increases ribozyme fidelity. Nucleic Acids Res (2005) 1.06
Molecular Validation of PACE4 as a Target in Prostate Cancer. Transl Oncol (2011) 1.05
Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs. Nucleic Acids Res (2005) 1.03
Unbiased in vitro selection reveals the unique character of the self-cleaving antigenomic HDV RNA sequence. Nucleic Acids Res (2006) 1.02
Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus. Nucleic Acids Res (2002) 0.98
Cross-linking experiments reveal the presence of novel structural features between a hepatitis delta virus ribozyme and its substrate. RNA (2004) 0.98
Kinetic and binding analysis of the catalytic involvement of ribose moieties of a trans-acting delta ribozyme. J Biol Chem (2002) 0.98
Single-molecule observation of the induction of k-turn RNA structure on binding L7Ae protein. Biophys J (2012) 0.97
Modulating RNA structure and catalysis: lessons from small cleaving ribozymes. Cell Mol Life Sci (2009) 0.96
In vitro selection and characterization of RNA aptamers binding thyroxine hormone. Biochem J (2007) 0.95
Functional characterization of the SOFA delta ribozyme. RNA (2005) 0.95
Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme. Curr Gene Ther (2007) 0.94
New scoring system to identify RNA G-quadruplex folding. Nucleic Acids Res (2013) 0.94
In-depth sequencing of the siRNAs associated with peach latent mosaic viroid infection. BMC Mol Biol (2010) 0.93
Characterization of a viroid-derived RNA promoter for the DNA-dependent RNA polymerase from Escherichia coli. Biochemistry (2002) 0.93
In-line probing of RNA G-quadruplexes. Methods (2013) 0.92
Identification of proteins from prunus persica that interact with peach latent mosaic viroid. J Virol (2009) 0.90
The use of a combination of computer-assisted structure prediction and SHAPE probing to elucidate the secondary structures of five viroids. Mol Plant Pathol (2012) 0.90
Gene targeting in the Gram-Positive bacterium Lactococcus lactis, using various delta ribozymes. Appl Environ Microbiol (2006) 0.89
Silencing of SPC2 expression using an engineered delta ribozyme in the mouse betaTC-3 endocrine cell line. J Biol Chem (2004) 0.89
Monitoring of an RNA multistep folding pathway by isothermal titration calorimetry. Biophys J (2009) 0.89
A novel structural rearrangement of hepatitis delta virus antigenomic ribozyme. Nucleic Acids Res (2007) 0.88
The RNA strands of the plus and minus polarities of peach latent mosaic viroid fold into different structures. RNA (2010) 0.86
Mapping studies of the Peach latent mosaic viroid reveal novel structural features. Mol Plant Pathol (2011) 0.86
In vitro and in vivo cleavage of HIV-1 RNA by new SOFA-HDV ribozymes and their potential to inhibit viral replication. RNA Biol (2011) 0.86
Tumor microenvironment-associated modifications of alternative splicing. RNA (2013) 0.85
RiboSubstrates: a web application addressing the cleavage specificities of ribozymes in designated genomes. BMC Bioinformatics (2006) 0.84
Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element. Nucleic Acids Res (2008) 0.84
Investigating a new generation of ribozymes in order to target HCV. PLoS One (2010) 0.84
Examination of the folding pathway of the antigenomic hepatitis delta virus ribozyme reveals key interactions of the L3 loop. RNA (2006) 0.84
Redirecting splicing with bifunctional oligonucleotides. Nucleic Acids Res (2013) 0.84
Potassium ions modulate a G-quadruplex-ribozyme's activity. RNA (2008) 0.84
Characterization of the trans Watson-Crick GU base pair located in the catalytic core of the antigenomic HDV ribozyme. PLoS One (2012) 0.83
Identification of a peach latent mosaic viroid hairpin able to act as a Dicer-like substrate. J Virol (2005) 0.83
Identification of quorum sensing-controlled genes in Burkholderia ambifaria. Microbiologyopen (2013) 0.82
Kinetic and thermodynamic characterization of the RNA guanylyltransferase reaction. Biochemistry (2008) 0.82
RTAnalyzer: a web application for finding new retrotransposons and detecting L1 retrotransposition signatures. Nucleic Acids Res (2007) 0.82
Binding site of Escherichia coli RNA polymerase to an RNA promoter. Biochem Biophys Res Commun (2004) 0.82
Elucidation of the structures of all members of the Avsunviroidae family. Mol Plant Pathol (2014) 0.80
Development of an efficient cis-trans-cis ribozyme cassette to inactivate plant genes. Plant Biotechnol J (2003) 0.80
Design and evaluation of clinically relevant SOFA-HDV ribozymes targeting HIV RNA. Methods Mol Biol (2014) 0.80
The peach latent mosaic viroid replication initiation site is located at a universal position that appears to be defined by a conserved sequence. Virology (2008) 0.80
Magnesium-binding studies reveal fundamental differences between closely related RNA triphosphatases. Nucleic Acids Res (2007) 0.79
Insights into the molecular determinants involved in cap recognition by the vaccinia virus D10 decapping enzyme. Nucleic Acids Res (2010) 0.79
Programming a highly structured ribozyme into complex allostery using RNA oligonucleotides. ACS Chem Biol (2012) 0.79
A modern mode of activation for nucleic acid enzymes. PLoS One (2007) 0.79
Expression strategy of Aedes albopictus densovirus. J Virol (2013) 0.79
Target-induced SOFA-HDV ribozyme. Methods Mol Biol (2012) 0.79
Finding instances of riboswitches and ribozymes by homology search of structured RNA with Infernal. Methods Mol Biol (2014) 0.78
A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease. PLoS One (2011) 0.78
Characterization of the MCT-1 pseudogene: identification and implication of its location in a highly amplified region of chromosome 20. Biochim Biophys Acta (2006) 0.78
Characterization of the vaccinia virus D10 decapping enzyme provides evidence for a two-metal-ion mechanism. Biochem J (2009) 0.78
Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting. Nucleic Acid Ther (2011) 0.76
Short RNA duplexes guide sequence-dependent cleavage by human Dicer. RNA (2010) 0.76
Silencing of amyloid precursor protein expression using a new engineered delta ribozyme. Int J Alzheimers Dis (2012) 0.75